04.10.26 -- The Systems And Choreography Needed For Grade B ATMP Material Transfer

Review this step-by-step guidance for fluorescent western blot detection, including membrane prep and antibody handling, to improve signal clarity and consistency across imaging platforms.

Digital PCR enables fast, sensitive mycoplasma detection in cell-based products. Explore how this pharmacopeia-compliant workflow improves accuracy and supports reliable decision-making.

To manufacture your rare disease therapy cost effectively, partner with an experienced CDMO from the outset. The right partner will offer development, manufacturing, quality, and regulatory expertise.

New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.

Discover how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.

Crucial for efficacy, thermal stability in RNA/DNA therapies hinges on phosphoramidites: A study highlights key factors for process safety and quality in oligonucleotide development.

Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection.

Examine five critical considerations for freezing bottles, including uniform rate control, container integrity, and selecting the right freezing technology to maintain product stability.

Uncover how our capabilities in phage and yeast surface display can drive your next protein engineering or therapeutic antibody development project forward.

Cell culture media isn’t one-size-fits-all. Find out how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.

From automating repetitive tasks to optimizing complex bioprocesses, AI is reshaping biopharmaceutical manufacturing. See how AI is moving beyond trends to become a foundational element in the industry.

Delve into actionable strategies that can lead to higher success rates and smarter resource investment, paving the way for a successful path to IND submissions and commercialization.

Observe how bone marrow, umbilical cord, and adipose MSCs produce extracellular vesicles with distinct characteristics, and why 3D culture systems consistently outperform 2D platforms in productivity.

A systematic screen of 40 expression configurations delivered production-ready Fab-VHH conditions within 10 days, achieving 570 μg/mL titers with light chain-first orientation.

See why single-use cold-chain containers made with polytetrafluoroethylene fluoropolymers may be less susceptible to failure and breakage at cold temperatures.

Demand for single-use production tools, expertise, and capabilities continues to grow as innovative cell therapies evolve. However, concerns and misconceptions abound regarding single-use solutions.